Pentixapharm Holding AG (FRA:PTP)

Pentixapharm Holding AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024
Period Ending	Mar 31, 2025	Dec 31, 2024
Operating Revenue	0.14	0.78
Other Revenue	0.17	0.62
Revenue	0.31	1.4
Cost of Revenue	4.93	3.74
Gross Profit	-4.63	-2.33
Selling, General & Admin	2.86	2.26
Other Operating Expenses	2.07	2.73
Operating Expenses	5.91	5.06
Operating Income	-10.53	-7.39
Interest Expense	-0.05	-0.1
Interest & Investment Income	0.48	0.57
Currency Exchange Gain (Loss)	0.01	0.01
EBT Excluding Unusual Items	-10.07	-6.91
Impairment of Goodwill	-0.78	-0.78
Gain (Loss) on Sale of Assets	6.7	6.7
Asset Writedown	-18.24	-18.24
Other Unusual Items	1.72	1.72
Pretax Income	-20.66	-17.5
Income Tax Expense	-3.81	-3.52
Net Income	-16.86	-13.98
Net Income to Common	-16.86	-13.98
Shares Outstanding (Basic)	25	25
Shares Outstanding (Diluted)	25	25
EPS (Basic)	-0.68	-0.56
EPS (Diluted)	-0.68	-0.57
Free Cash Flow	-9.57	-7.35
Free Cash Flow Per Share	-0.39	-0.30
Gross Margin	-	-166.38%
Operating Margin	-3442.16%	-527.20%
Profit Margin	-5508.50%	-996.43%
Free Cash Flow Margin	-3126.14%	-524.24%
EBITDA	-9.56	-7.33
D&A For EBITDA	0.97	0.07
EBIT	-10.53	-7.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.